Thomas Gajewski, MD, PhD, investigates and develops new treatments for patients with melanoma. He has a special interest in the development of immunotherapies against this disease. Dr. Gajewski also leads development of immune-based therapies for other cancers, using new laboratory data on how the immune system is regulated to develop novel clinical trials.

Dr. Gajewski serves as an editor for Cancer Research and Journal for Immunotherapy of Cancer. In addition, he is immediate past president of the Society for Immunotherapy of Cancer and has served on the program committees for the American Society for Clinical Oncology (ASCO) and the American Association for Cancer Research (AACR).

Areas of Expertise

Education

The University of Chicago Pritzker School of Medicine

Additional Education

  • Internship: University of Chicago Medicine
  • Residency: University of Chicago Medicine
  • Fellowship: University of Chicago Medicine

Memberships & Medical Societies

  • American Society of Clinical Oncology
  • American Association of Immunologists
  • American Association of Cancer Research
  • Society for Immunotherapy of Cancer
  • Aetna POS
  • Aetna HMO
  • Aetna PPO
  • BCBS Blue Precision HMO
  • BCBS HMO (HMOI)
  • BCBS PPO
  • Cigna HMO
  • Cigna POS
  • Cigna PPO
  • CountyCare
  • Coventry Health Plan PPO
  • Great West PPO
  • Illinicare
  • Medicare
  • Multiplan PPO
  • PHCS PPO
  • United Choice / Choice Plus
  • United Options (PPO)
  • United Select (HMO & EPO)
  • United W500 Emergent Wrap
To Request an Appointment

Duchossois Center for Advanced Medicine (DCAM) - Hyde Park

Request an Appointment at Duchossois Center for Advanced Medicine (DCAM) - Hyde Park or call UCM Connect at 1-888-824-0200

To Refer a Patient

Refer a Patient or call UCM Connect at 1-888-824-0200

At a Glance

Practicing Since1993

Board Certifications

  • Medical Oncology

Languages Spoken

  • English